Altium Capital Management LP Rhythm Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $1.99 Million - $2.66 Million	50,786 Added 783.13%	57,271 $2.48 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $138,714 - $321,915	6,485 New	6,485 $298,000
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $731,000 - $5.24 Million	170,000 New	170,000 $4.17 Million
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $1.22 Million - $2.17 Million	-104,840 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$18.52 - $22.55 $2.19 Million - $2.66 Million	-118,160 Reduced 52.99%	104,840 $2.05 Million
Q1 2021 May 06, 2021	BUY	$20.25 - $39.49 $4.52 Million - $8.81 Million	223,000 New	223,000 $4.74 Million

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.